GCG and cancer: Instead, other anti-diabetic agents not belonging to GLP-1RA class, including metformin, might only have an indirect effect on GLP-1 pathway and on PDAC stroma preventing cancer development through different mechanisms, mainly harnessing PDAC cancer cells [80].